The blood eosinophil count as a biomarker in COPD

Mona Bafadhel (Oxford, United Kingdom)

Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Session: Individualised risk reduction strategies for patients with COPD
Session type: Symposium
Number: 1940
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mona Bafadhel (Oxford, United Kingdom). The blood eosinophil count as a biomarker in COPD. International Congress 2015 – Individualised risk reduction strategies for patients with COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018



Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Peripheral eosinophil count as a biomarker for the management of COPD: not there yet
Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017
Year: 2017



Blood eosinophil as a biomarker in COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003

Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


The search for the “healthy” blood eosinophil count
Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020
Year: 2020



Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
Source: Eur Respir J 2016; 47:1562-1564
Year: 2016


Stability of sputum and blood eosinophil levels in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Mepolizumab does not alter blood basophil count in severe asthma
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010

Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Blood eosinophil counts in COPD patients compared to controls
Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019
Year: 2019



Lack of seasonal variability of blood eosinophil counts in COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease
Source: Eur Respir J 2016; 47:1299-1303
Year: 2016